- Home
- LPA vs BNTC Comparison
LPA vs BNTC Comparison
Compare LPA & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPA
- BNTC
- Stock Information
- Founded
- LPA 2013
- BNTC 1995
- Country
- LPA United States
- BNTC United States
- Employees
- LPA N/A
- BNTC N/A
- Industry
- LPA
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- LPA
- BNTC Health Care
- Exchange
- LPA Nasdaq
- BNTC Nasdaq
- Market Cap
- LPA 227.0M
- BNTC 366.6M
- IPO Year
- LPA N/A
- BNTC N/A
- Fundamental
- Price
- LPA $7.51
- BNTC $13.17
- Analyst Decision
- LPA
- BNTC Strong Buy
- Analyst Count
- LPA 0
- BNTC 6
- Target Price
- LPA N/A
- BNTC $23.83
- AVG Volume (30 Days)
- LPA 29.9K
- BNTC 226.1K
- Earning Date
- LPA 08-14-2025
- BNTC 05-14-2025
- Dividend Yield
- LPA N/A
- BNTC N/A
- EPS Growth
- LPA N/A
- BNTC N/A
- EPS
- LPA 0.57
- BNTC N/A
- Revenue
- LPA $45,218,701.00
- BNTC N/A
- Revenue This Year
- LPA N/A
- BNTC N/A
- Revenue Next Year
- LPA N/A
- BNTC N/A
- P/E Ratio
- LPA $13.22
- BNTC N/A
- Revenue Growth
- LPA 7.03
- BNTC N/A
- 52 Week Low
- LPA $5.90
- BNTC $7.05
- 52 Week High
- LPA $32.00
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- LPA N/A
- BNTC 44.14
- Support Level
- LPA N/A
- BNTC $10.91
- Resistance Level
- LPA N/A
- BNTC $12.74
- Average True Range (ATR)
- LPA 0.00
- BNTC 1.37
- MACD
- LPA 0.00
- BNTC -0.29
- Stochastic Oscillator
- LPA 0.00
- BNTC 36.51
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.